Estimated mortality rates of individuals with sickle cell disease in Brazil: real-world evidence
Authors:
- Rodolfo Delfini CançadoRCRodolfo Delfini Cançado
- Fernando Ferreira CostaFCFernando Ferreira Costa
- Clarisse LoboCLClarisse Lobo
- Celina Borges MigliavacaCMCelina Borges Migliavaca
- Maicon FalavignaMFMaicon Falavigna
- Homero C. R. Souza FilhoHFHomero C. R. Souza Filho
- Carolina Tosin BuenoCBCarolina Tosin Bueno
- Ana Cristina Silva-PintoASAna Cristina Silva-Pinto
Open Access
- 26 July 2023
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 7 (15) , 3783-3792
Abstract
Sickle cell disease (SCD) is a group of hereditary chronic diseases with a substantial impact on quality of life and morbimortality. In Brazil, it is 1 of the most common hereditary diseases; however, there are sparse epidemiological data for the country. Using data from death certificates, we aimed to estimate the median age at death, years of life lost because of SCD, and the median survival. From 2015 to 2019, we identified 3320 records of deaths of individuals with SCD, from a total of 6 553 132 death records. Among individuals with SCD, the median age at death was 37 years less than that of the general population (SCD: aged 32.0 years at death, interquartile range [IQR], 19.0-46.0; general population: aged 69.0 years at death; IQR, 53.0-81.0). Results were consistent when stratified by sex or race. Over the 5 years evaluated, crude death rates varied from 0.30 to 0.34 per 100 000 inhabitants (mean 0.32 per 100 000 inhabitants). We estimated a prevalence of 60 017 individuals living with SCD (29.02 cases per 100 000) and an average incidence of 1362 cases yearly. The median estimated survival was 40 years for individuals with SCD and 80 years for the general population. SCD was associated with an increased risk of mortality in most age ranges. Among individuals with SCD aged between 1 and 9 years and between 10 and 39 years, the risk of death was 32 and 13 times higher, respectively. The most common causes of death were sepsis and respiratory failure. These results highlight the burden of SCD in Brazil and the necessity of improved care for this population.Keywords
This publication has 33 references indexed in Scilit:
- Survival of children with sickle cell disease in the comprehensive newborn screening programme in Minas Gerais, BrazilPaediatrics and International Child Health, 2015
- The relationship between genotype, psychiatric symptoms and quality of life in adult patients with sickle cell disease in São Paulo, Brazil: a cross-sectional studySao Paulo Medical Journal, 2015
- Characterization of mortality in children with sickle cell disease diagnosed through the Newborn Screening ProgramJornal de Pediatria, 2015
- Trends in mortality and hospital admissions of sickle cell disease patients before and after the newborn screening program in Maranhão, BrazilRevista Brasileira de Ginecologia e Obstetrícia, 2014
- Clinical complications in pregnant women with sickle cell disease: prospective study of factors predicting maternal death or near missRevista Brasileira de Ginecologia e Obstetrícia, 2014
- Newborn screening program for hemoglobinopathies in Rio de Janeiro, BrazilPediatric Blood & Cancer, 2013
- Global epidemiology of haemoglobin disorders and derived service indicatorsBulletin of the World Health Organization, 2008
- Alcohol Abuse in Sickle Cell Disease: The Pisces ProjectThe American Journal on Addictions, 2007
- A doença falciforme no BrasilRevista Brasileira de Ginecologia e Obstetrícia, 2007
- Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population studyThe Lancet, 2001